Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma.

导出 LinkOut

翻译打印收藏纠错

作者： Arnaud,Jacquerie ^[1] ; Ann,Hoeben ^[2] ; Daniëlle B P,Eekers ^[3] ; Alida A,Postma ^[4] ; Maxime,Vanmechelen ^[5] ; Frederik,de Smet ^[6] ; Linda,Ackermans ^[5] ; Monique,Anten ^[6] ; Kim,Severens ^[7] ; Axel,Zur Hausen ^[8] ; Martinus P G,Broen ^[9] ; Jan,Beckervordersandforth ^[9]

作者单位： Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. arnaud.jacquerie@mumc.nl. ^[1] Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[2] Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[3] Department of Radiology and Nuclear Medicine, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[4] Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. ^[5] LISCO-KU Leuven Institute for Single Cell Omics, KU Leuven, Leuven, Belgium. ^[6] Department of Neurosurgery, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[7] Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[8] Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands. ^[9]

关键词 AhR Glioblastoma IDO Kynurenine Prognosis TDO2